Benzinga | Jan 7, 2022 01:07PM EST

Craig-Hallum Upgrades HTG Molecular Diagnostics to Buy, Raises Price Target to $8

Craig-Hallum analyst Alexander Nowak upgrades HTG Molecular Diagnostics (NASDAQ:HTGM) from Hold to Buy and raises the price target from $5 to $8.